Gilead Sues Sigmapharm Over Hepatitis B Generic
Gilead Sciences Inc. has sued Sigmapharm Laboratories LLC over its attempt to introduce a generic version of chronic hepatitis B drug Hepsera despite two patents covering the treatment....To view the full article, register now.
Already a subscriber? Click here to view full article